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gelatinous. Lately the specific symptom 
does not always evident anymore, although 
in our previous study all isolates were 
serologi cally identified as Avian Influenza 
Virus (AIV) H5N1 sub-type (Wibowo et al.,  
2006).
Avian Influenza Virus is a member of 
Orthomyxoviridae family, consist of a 
segmented, single stranded, and negative 
sense RNA genome (Fenner et al., 1993; 
Easterday et al., 1997). The virus has a wide 
range of hosts. Poultry, mammalian, deep 
whale and human could be infected by AIV. 
So far the water fowls and wild birds 
considered as the potential reservoir of the 
virus, and exhibited without clinical signs 
(Zhou et al., 1999; Lipatov et al., 2004). 
Virions envelope have glycoprotein 
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Abstract
Highly pathogenic avian influenza virus (HPAI) differ from Low pathogenic avian influenza virus (LPAI) based 
on multiple basic amino acid motif of the carboxylterminus of HA1, especially arginine and lysine. The propose of 
this work was toamplify and sequence the cleavage site region of HA gene of avian influenza virusisolated from both 
cases with characteristic or unspecific lesion, using reversetranscriptase polymerase chain reaction (RT-PCR). Primer 
desaigned for amplification and sequence was H5-F: 5’ ggagactcagcaatcccatgaaaag 3’ and H5-
R:5’ccataccaaccgtctaccattcc 3’, and expected product size was 246 bp. The result indicated that all avian influenza 
virus (AIV)-isolates originated from chicken with both specific and non specific lesion show a multiple basic amino 
acid motif -PQRERRRKKR//GLF- and classified as highly pathogenic avian influenza. Philogenetic study of HA 
genefragment indicated that each type of characteristic lesion created philo-groups.
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Introduction
Highly pathogenic Avian Influenza 
(HPAI) outbreak has been reported in 
Indonesia since 2003 and still continuously 
circulated, due to H5N1 sub-type. The field 
examination focused on clinical signs of the 
disease that indicated some changes in 
macroscopic lesions. Formerly the bird 
exhibited characteristic symptoms, e.g.: high 
mortality rate, hemorrhages on shank and 
hock joint, congestion and cyanosis of comb 
and wattle, which can be followed by edema 
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projection called Hemagglutinin (HA) and 
Neuraminidase (NA). Approximately 80% 
o f  t h e  s u r f a c e ’ s  p r o j e c t i o n s  a r e  
Hemagglutinin and the remaining 
Neuraminidase (McCaulay and Mahy, 
1983). Antigenic properties of HA and NA 
glycoprotein determine the sub-type 
specifity of AIV. Currently, it has been 
recognized 16-H and 9-N (Suzuki and Nei, 
2002; Fourchier et al., 2005). Hemagglutinin 
is viral glycoprotein which  is  res-ponsible 
for both receptor binding and membrane 
fusion that in turn will facilitate the infection 
(Matrosovich et al., 1999; Mitnaul et al., 2000; 
Suzuki et al., 2000). In addition to its binding 
and fusion functions it is the primary target 
for neutralizing antibodies.
Although the pathogenicity of AIV is 
polygenic  trai t ,  the  HA’s  surface  
glycoprotein still play a central role 
(McCauley and Mahy, 1983; Ito et al., 2000). 
The process of the infection, HA will be 
cleaved by certain protease enzyme into 
HA1 and HA2 sub-unit. The HA1 is receptor 
binding protein as the major target of 
immune responses, whereas HA2 is an 
anchor protein of the envelope and mediates 
fusion of the envelope and the cellular 
endosomal membrane (Suzuki and Nei, 
2002). Another worker emphasize that the 
cleavage process on HA region will 
determine further infection.
 Cleavage site region of HPAI viruses 
differ from those of avirulent influenza a 
viruses by the virtue of possessing multiple 
basic amino acid of the carboxyl terminus of 
HA1, especially arginine and lysine. This 
feature permits cellular protease such as 
furine will recognize multiple basic amino 
acid, to cleave the HA and render the virus 
infection and able to spread to a variety 
organs, leading to systemic infection. 
Whereas most avirulent strain have a single 
arginine or monobasic cleavage site that will 
cleaved only by tripsin which secreted from 
cells in the respiratory and intestinal tract, so 
the virus only produced localized infection 
(Harimoto and Kawaoka, 2001; Ito et al., 
2001). Specific motif consisting of a basic 
amino acid series at the cleavage site is  
RRRKKR//GL- (Dharmayanti et al., 2005) or 
–RRRKKR//G- (Harimoto and Kawaoka, 
1994). Most of the motif has been identified 
for AIV H5N1 sub-type in Indonesia. The 
presence of the polybasic amino acid region 
is important as pathotypic marker of AIV 
(Bank and Polywright, 2003).
Based on fascinating fact, the aim of this 
study is to determine the molecular 
pathogenicity marker of both AIV isolates by 
amplifying and sequencing the cleavage site 
region of the hemagglutinin. 
Materials and Methods 
Ten isolates have been identified using 
RT-PCR. Four isolates were obtained from 
birds without specific symptoms. Six 
isolates were obtained from birds that 
indicated characteristic lesion of avian 
influenza virus infection.
Viral RNA extraction
Viral RNA was extracted from allantoic 
fluid using RNA extraction kit Invitrogen 
Pure Link™ Micro to Midi 50xRxn Total 
RNA Purification System (Cat. no: 12183- 
018) according to the manufacturer’s 
protocol. To purify total RNA from 0.2 ml 
allantoic fluid, in a 1.5 ml RNAse-free micro 
centrifuge tube was added 0.2 ml of RNA 
lysis solution contain 1% (v/v) 2-
mercaptoethanol. The mixture was vortexed 
throughly to disrupt lyse blood cells, and 
centrifuged at 12,000xg for 2 min at room 
temperature. Supernatant was transferred to 
clean 1.5 ml RNAse-free microcentrifuge 
tube and 200 ml of 100% ethanol was added. 
Any precipitate was dispersed by vortexing 
or pipetting up and down several times. The 
sample was transferred to the RNA spin 
cartridge, centrifuged at 12,000xg for 15 s at 
room temperature. The flow-through was 
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discarded. This step was repeated once. The 
spin cartridge was centrifuged at 12,000xg 
for 1 min at room temperature to dry the 
membrane, and the cartridge was moved 
into an RNA recovery tube. Fifty microliters 
of RNase-free water was added to elute the 
RNA and incubated for 1 min at room 
temperature then centrifuged for 2 min at 
12,000xg at room temperature. This step was 
repeated once, after that the cartridge was 
discarded and elutes was stored at -4°C.
Thermocycling condition
One step Reverse transcriptase-PCR 
(RT-PCR) was carried out in GeneAmp® 
PCR System 2400 machine and performed 
using Invitrogen SuperScript™ III One-Step 
RT-PCR System. Cycling conditions 
included a reverse transcription step at 50°C 
for 30 min. After an initial denaturation step 
at 94°C for 5 min, amplification was 
performed during 40 cycles including 
denaturation (94°C for 30 s), annealing (50°C 
for 1 min) and extension (68°C for 45 s), 
followed by final extension at 68°C for 5 min. 
Primer designed for this amplification and 
s e q u e n c e  w a s  H 5 - F :  5 ’  
ggagactcagcaatcccatgaaaag 3’ and H5-R: 
5’ccataccaaccgtctaccattcc 3’, which has 
expected product size was 246 bp (Ito et al., 
2001).
 
Electrophoresis of PCR product 
PCR product were electrophoresis in 
1.5% agarose gel in 1x TBE, using 
Electrophoresis tank  (MSMIDIDUO, 
Cleaver Scientific Ltd), at 100V for 40 min, 
and read under UV transillumination at 302 
nm wave length to determine the size of PCR 
product fragment.
 
Sequencing of PCR product 
Fragment  HA sequenc ing  was  
performed with Dye Terminator Cycle 
Sequencing method using ABI PRISM 377A 
model version 3.4.1. All process was done at 
BPPT, Gene Technology Laboratory, 
Tangerang, Jawa Barat. 
Sequence Analyses 
Nucleotide sequences were analyzed by 
using Clustal W version 1.83 and Phyllip 
version 3.65 to determine their genetic 
relationship. 
Discussion 
In order to AIV molecular identification, 
the important and basic thing in this study 
was  to  understand virus  isolates  
pathogenicity HPAI similarity which taken 
from different clinical character cases, by 
identified the amino acid motif on cleavage 
site region. We found polybasic amino acid 
region on HPAI that especially being filled 
by arginine and lysine. In LPAI virus, in that 
restricted site only have single arginine, 
which is why this motif could be used as AIV 
pathotypic marker (Kawaoka et al.,1984; 
Swayne and Suarez, 2000; Banks and 
Polywright, 2003). The amplification of 
cleavage site of HA gene fragment at 
position 775 to 1021 was based on Ito et al. 
(2001), and the result can be seen in the 
Figure 1.  
 
All 10 RT-PCR products were sent to 
BPPT to have them sequenced. Only 7 out of 
10 samples give good results amino acids 
sequences at cleavage site deducted from 
Figure 1. Gel electrophoresis indicated DNA band of 
expected product size (246 bp), on cleavage site 
region.Line no 1,2,3,& 6 are samples without specific 
symptoms; Line no 4,5,7,8,9 & 10 are samples with 
characteristic lesion of AIV 
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nucleotide sequences  (Table 1).
 
Table 1. Translation of amino acid sequence at 
cleavage site region of seven AIV isolates.
According to Senne et al., (1996), 
minimal motif amino acid concept is 
BXBR//, which B is basic amino acid, X is 
non basic amino acid and R is arginine that 
related to restriction area (sign //). Follow in 
amino acid level conversion, samples 
number 1, 2, 3 and 9 that are virus isolates 
from unspecific lesion case have same motif 
with samples number 4, 5, and 7 from 
characteristic case of AI disease. Amino acid 
motif in the restriction area above (Tab-2) 
fulfill the minimal concept of HPAI virus 
according to Senne et al., (1996) and it still 
consistent with few kind of studies that 
reported by another researcher.
In general amino acid motif at cleavage 
site of HPAIV-H5 is: -RRRKKR//GL- 
(Dharmayanti et al., 2005) or –RRKKR//GL- 
(Ito et al., 2001). Basic amino acid series in this 
study have same motif with isolates that 
reported by Zhou et al., (1999) to upstream-
10: -PQRERRRKKR//. The origin of this 
basic amino acid series was from human 
isolate (A/Hong Kong/156/97), 11 isolates 
from chicken, i.e.: A/chicken/Hong 
K o n g / 1 9 9 7  a n d  2  d u c k  i s o l a t e s  
(A/Duck/Hong Kong/1997) that isolated in 
Hong Kong (1997). All isolates have been 
confirmed as AIV pathogenic for chicken 
based on the pathogenic marker of the 
cleavage site position. This amino acid motif 
in this study show a bit different with motif 
that reported by Senne et al. (1996). In the 
cleavage site, we found 3 different pattern 
that showed until upstream-10 and 
downstream+3: -PQ—RKRKKR//GLF or 
– P Q R E T R R Q K R / / G L F -  o r  – P Q —  
RKRKTR//GLF- (Senne et al., 1996). The 
first motif is very clear because of basic 
amino acid repetition to upstream–6, 
whereas the second motif still consistent in 
minimal concept: BXBR//. In the third 
motif, amino acid position on upstream-2 
filled by Threonine (T) that belonging to 
alcohol group, replacing Arginine or Lycine. 
This unusual phenomenon still considered 
as HPAI because of the basic amino acid 
repetition in upstream-3 to -6. In his view the 
second position became unimportant, as far 
as this motif still has a repetition of basic 
amino acid in upstream  -3 to -6. 
Most AIV have Arginine (R) on terminal 
carboxy HA-1 at upstream-1 position, 
   No Sample No Amino Acid
                & Code sequence
Sample 1
    1 A/layer/K. PQRERRRKKR/GL
Progo/01/
2004
(H5N1)
Sample 2
    2 A/puyuh/ PQRERRRKKR/GL
Bantul/02/
2005
(H5N1)
Sample 3
    3 A/layer/ PQRERRRKKR/GL
Magelang/
04/2005
(H5N1)
Sample 6
    4 A/broiler/ PQRERRRKKR/GL
Klaten/09/
2005
(H5N1)
Sample 8
    5 A/layer/ PQRERRRKKR/GL
Purwokerto
/12/2003
(H5N1)
Sample 9
     6 A/layer/ PQRERRRKKR/GL
Klaten/13/
2003
(H5N1)
Sample 10
    7 A/layer/ PQRERRRKKR/GL
Lampung/
14/2004
(H5N1)
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whereas upstream-9 and -10 is the proximal 
end that according to another similar study 
this position always placed by amino acid 
Glutamine at position-9 and Proline at 
position-10  and these  position so far 
considered as conserved region (Senne et al., 
1 9 9 6 ;  Z h o u  e t  a l . ,  1 9 9 9 ) .  I s o l a t e  
A/Gull/PA/4175/83 have been reported 
that on upstream-1 position Arginine (R) 
was substituted with Lycine (K), and the 
motif is – RETK//GL- (Senne et al., 1996). 
Amino acid position at downstream +1, +2 
so far still Glycine (G) and Leucine (L), both 
are aliphatic amino acid. This result 
supported by Dharmayanti et al. (2005), Ito et 
al. (2001), Senne et al. (1996), and Zhou et al. 
(1999). In this study, we still can found 
consistency of amino acid motif at upstream-
1 which is Arginine (R), Glutamine (Q) at 
upstream-9 and Proline (P) at upstream-10 
as well as Glycine (G) and Leusin (L) at 
downstream+1 and +2. 
The philogenetic tree analysis of the 230 
bp of HA gene fragment around the cleavage 
site can be seen in the Figure 2. The result is 
very interesting since all isolates analyzed 
here, have the same multiple basic amino 
acid motif in the cleavage site region but 
created two kind of philogroups, based on 
Sandong isolate, gene bank accesion number 
DQ767725. From the diagram shown that 
our isolates were have different genetic 
relationship from Sandong AIV isolate. 
Avian influenza virus isolates codes number 
1, 2, 4 and 9 have closely genetic relationship 
among other and created as one cluster 
meanwhile isolates codes number 12, 13 and 
14, create another cluster that may different 
f rom that  one .  According  to  the  
characteristic type of lesion isolates codes 
number: 1, 2, 4 and 9 taken from unspecific 
lesion to AIV whereas reset of three isolates 
obtained from specific lesion for AIV.
 
Conclusion
1. All AIV-H5 isolates originated from 
chicken with specific or non specific lesion   
have multiple basic amino acid motif at 
cleavage site, that is -PQRERRRKKR//GLF- 
and classified as highly pathogenic avian 
influenza.
2. Philogenetic analysis of 230 bp of HA 
gene fragment around the cleavage site 
region, created two kinds of philo-groups for 
each type of characteristic lesion.
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